Curvebeam Ai Ltd. · ASX:CVB
Curvebeam Ai — Investor Presentation (August 2023)
30 slides from Curvebeam Ai's investor presentation, Aug 23, 2023
Slide 1: Investor Presentation August 2023
For personal use only INVESTOR PRESENTATION August 2023
Slide 2: Disclaimer
DISCLAIMER Introduction or its directors and therefore any investment is considered to be speculative in nature. THIS DOCUMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA OR TO ANY Forward looking state
Slide 3: Executive Summary
EXECUTIVE SUMMARY • CurveBeam AI is a developer and manufacturer of natural bilateral weight bearing CT devices • Targeting improved visual assessment for doctor diagnosis, prognosis and management of orthopaedic and bone health issues Company overview • Corporate HQ in Melbourne. Operational HQ in
Slide 4: Investment Highlights
CurveBeam AI’s HiRise Weight bearing CT INVESTMENT HIGHLIGHTS For personal use only Combining Weight Bearing CT (WBCT) imaging equipment with AI solutions to target faster, First to market Growing sales Natural bilateral WBCT & Non WBCT, point of A$11.48m FY23 pro-forma revenue, circa 55% more effic
Slide 5: CurveBeam AI CT Devices & AI Solutions
CURVEBEAM AI CT DEVICES & AI SOLUTIONS CurveBeam AI has a range of CT imaging devices with visualisation applications in orthopaedics and bone health. CurveBeam AI’s imaging devices have regulatory clearances and will provide the platform for the company’s AI modules (post regulatory clearances) For
Slide 6: Commercialisation Strategy
For personal use only 01 COMMERCIALISATION STRATEGY 6 INVESTOR PRESENTATIO N
Slide 7: Land & Expand Commercialisation Strategy
LAND & EXPAND COMMERCIALISATION STRATEGY With over 170 first & second-generation installations worldwide, CurveBeam AI is well placed to upgrade its global install base to the HiRise for targeting high margin AI module revenue For personal use only NORTH AMERICA Operations HQ • CurveBeam AI utilises
Slide 8: Large Market Opportunity and Ongoing Adoption by Leading Customers
LARGE MARKET OPPORTUNITY AND ONGOING ADOPTION BY LEADING CUSTOMERS For personal use only CurveBeam AI’s target Potential US WBCT Potential US customer groups Installation Sites1 Addressable Market2 Select CurveBeam AI customers • Mayo Clinics (all 3 major locations) Orthopaedic Surgeons & Group Prac
Slide 9: Strong Investment Proposition for Surgeons
STRONG INVESTMENT PROPOSITION FOR SURGEONS Existing reimbursement codes create an attractive financial model for HiRise users For personal use only • The average Medicare reimbursement rate for scans of the lower extremity CPT code relevant to the HiRise™, pedCAT™ and LineUP™ was US$138.77 per scan
Slide 10: Stryker Foot & Ankle Co-Marketing & Distribution US Partnership
STRYKER FOOT & ANKLE CO-MARKETING & DISTRIBUTION US PARTNERSHIP Stryker is a market leader in orthopaedics with US$18b in sales in FY22. For personal use only STRYKER CORPORATION (NYSE:SYK) BACKGROUND • Leading multinational medical technology company with innovative products and services in Medical
Slide 11: Stryker Co-Marketing & Distribution Partnership
STRYKER CO-MARKETING & DISTRIBUTION PARTNERSHIP US Foot & Ankle agreement. Stryker targets HiRise placements to drive sales of their For personal use only orthopaedic product suite CURVEBEAM AI & STRYKER PARTNERSHIP • US Co-marketing & Distribution partnership - Stryker Foot & Ankle Division • Launc
Slide 12: Regulatory & Reimbursement Overview
REGULATORY & REIMBURSEMENT OVERVIEW Over 10 years of regulatory and clinical development and clearances underpin CurveBeam AI’s industry leading competitive position For personal use only • FDA cleared, CE Marked and ARTG listed for CT devices and visualisation software to allow the sale of CurveBea
Slide 13: Orthopaedic Diagnosis and Planning
For personal use only 03 ORTHOPAEDIC DIAGNOSIS AND PLANNING 13 I N V E S T O R P R E S E N T A T I O N
Slide 14: Weight Bearing Cone Beam CT for Total Alignment
WEIGHT BEARING CONE BEAM CT FOR TOTAL ALIGNMENT ✓ Quicker and easier to scan than traditional CT and MRI, ✓ Radiation dose lower than traditional CT – up to 66% less with faster image acquisition time than traditional CT For personal use only ✓ High resolution and 3D visualisation enables ✓ Smaller
Slide 15: HiRise: Weight Bearing CT Applications Currently Served
HIRISE: WEIGHT BEARING CT APPLICATIONS CURRENTLY The HiRise currently provides many advantages in improving CT visualisation of clinical issues to SERVED improve diagnosis and surgical planning For personal use only • Suspected hip, knee • Charcot foot and ankle fractures reconstruction • Suspected
Slide 16: User Testimonials
USER TESTIMONIALS “ “ We all know that the 3D morphology is overlapping and it’s sometimes For personal use only The image quality is very difficult to tell on plain films. So, this really does heighten our unparalleled and the ability to make a diagnosis and examine patients. efficiencies are inval
Slide 17: User Testimonials
USER TESTIMONIALS For personal use only • In 2020, President Joe Biden’s physician recommended he get a weight bearing CT scan to monitor the healing progression of a sustained hairline fracture • President Biden was scanned by a pedCAT weight bearing CT system • “It is important to observe the stru
Slide 18: AI Modules Will Target High Margin Revenue on HiRise Install Base
AI MODULES WILL TARGET HIGH MARGIN REVENUE ON HIRISE INSTALL BASE For personal use only CubeVue AutoMetrics aims to reduce 16 hours of CT dataset preparation prior to pre-surgical planning to a scan available in 15 minutes "To minimize future predicted costs, morbidity, THE PROBLEM THE SOLUTION & mo
Slide 19: Bone Health Diagnostics
For personal use only 04 BONE HEALTH DIAGNOSTICS 19 I N V E S T O R P R E S E N T A T I O N
Slide 20: Musculoskeletal Issues Are Significant for Health Care Systems
MUSCULOSKELETAL ISSUES ARE SIGNIFICANT FOR HEALTH CARE SYSTEMS Enhanced imaging data can aid in the clinical assessment and treatment of Osteoarthritis and Osteoporosis For personal use only Estimated cost to US Health Care System (US$b) OSTEOPOROSIS 70 65.5 • Osteoporosis is where bone mass, struct
Slide 21: Current Bone Health Diagnostic (DEXA) Misses the Majority of Fragility Fractures
BONE HEALTH: CURRENT BONE HEALTH DIAGNOSTIC (DEXA) MISSES THE MAJORITY OF FRAGILITY FRACTURES For personal use only Bone fragility is caused by loss of bone microstructure, BONE FRAGILITY = BONE MICROSTRUCTURE BMD measures only bone density & not microstructure BMD is measuring bone density not bone
Slide 22: BMD and OssView Overview
An over 60 yr old fracture patient suspected of fragility fracture goes to FLS – non-osteoporosis – Impact or Fragility Fx? BMD AND OSSVIEW OVERVIEW AWS CurveBeam AI’s proprietary SaaS solutions leverage CT scans generated from its HiRise device Step 1 Step 2 Step 3 Over 60 yr old fragility fracture
Slide 23: Micro-CT + AI Image Analysis Providing Bone Microstructure Assessment
THE CURVEBEAM AI SOLUTION: MICRO-CT + AI IMAGE ANALYSIS PROVIDING BONE MICROSTRUCTURE ASSESSMENT FOR FRACTURE RISK For personal use only CurveBeam AI’s specialised imaging and the OssView SFS modules are targeting to provide a step change in aiding a clinician in fracture risk assessment, with & wit
Slide 24: Experienced Board and Management
For personal use only 05 EXPERIENCED BOARD AND MANAGEMENT 24 I N V E S T O R P R E S E N T A T I O N
Slide 25: Experienced Board
EXPERIENCED BOARD For personal use only ROBERT LILLEY GREGORY BROWN ARUN SINGH HASHAN DE SILVA KATE ROBB Chairman, BA (Yale) Managing Director / Executive Director, Non-Executive Director, Non-Executive Director CEO, B.app.Sc, MBA COO, CTO-CT, US president 35 years’ experience in medical BSc (Medici
Slide 26: Senior Management
SENIOR MANAGEMENT For personal use only URA P AUCKLAND YU PENG S. TURNER DEAN VINTI SINGH CFO, Company Secretary CTO-AI, BSc & PhD Chief Sales Officer Vice President of Marketing, B.Bus, G.Dip Company Over 15 years’ experience in BA (Journalism), MBA Secretarial Practice, Columbia computer vision an
Slide 27: Summary
For personal use only 06 SUMMARY 27 I N V E S T O R P R E S E N T A T I O N
Slide 28: CurveBeam Technology Platform Overview
CURVEBEAM TECHNOLOGY PLATFORM OVERVIEW CurveBeam AI has regulatory clearances for WBCT devices in-market with a deep pipeline of complimentary high margin AI modules to be launched in FY25 and beyond REGULATORY/COMMERCIAL US MARKET GROSS REVENUE For personal use only SOLUTION PRODUCTS STATUS OPPORTU
Slide 29: Investment Summary
INVESTMENT SUMMARY CurveBeam AI produces and sells market leading weight bearing CT scanners. The Company has established key recognised clinical customers and a leading vendor partner. Funds raised in the IPO will be used to accelerate sales growth and invest in new product development to maintain
Slide 30: Thank You
For personal use only THANK YOU